Upper Tract Urothelial Carcinomas
1 clinical trials · Condition
◉ Watch Upper Tract Urothelial Carcinomas
| Record | Firm | Date |
|---|---|---|
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (NCT04197986) | QED Therapeutics, a BridgeBio company | 2020-03-11 |
Track Upper Tract Urothelial Carcinomas automatically
Every clearance here is in the API, with alerts when new ones post.